Hibbett, Inc.

Greetings and welcome to Hibbett, Inc.' 's first quarter fiscal year 2023 conference call. At this time, all participants are on a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Gavin Bell, Vice President of Investor Relations. Thank you. You may begin.

Thank you and good morning. Please note that we have prepared a slide deck that we will refer to during our prepared remarks. The slide deck is available on Hibbett.com via the investor relations link found at the bottom of the homepage or at investors.hibbett.com and under the news and events section. These materials may help you follow along with our discussion this morning. Before we begin, I would like to remind everyone that some of management's comments during this conference call are forward-looking statements. These statements which reflect the company's current views with respect to future events and financial performance

Say goodbye to multiple daily insulin injections with the new Omnipod 5, the only tubeless automated insulin delivery system that integrates with Dexcom G6, automatically adjusting your insulin to help protect against highs and lows day or night. Don't wait to simplify life with diabetes. Get started today with no contract and no commitment. Go to Omnipod.com for risk information and instructions for use. Consult your healthcare provider before starting on Omnipod. Simplify diabetes. Simplify life.